Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (38 ops.)
Latest filing published 06 Oct 2026 for Ligand Pharmaceuticals INC, €16k. Read the official filing
Filing timeline
BuySaleAndrew Reardon
Insider track record
Disclosed buys
0
Disclosed sells
38
Signal history
Andrew Reardon: trading record in brief
Andrew Reardon discloses dealings in Ligand Pharmaceuticals Inc to SEC (Form 4). The record holds 61 filings, for trades running from 30 November 2022 to 2 October 2026.
The open-market record consists of 38 sales worth €6.2M, with no purchase. Outside the open market, there are 11 share grants and 8 option exercises. So far in 2026, the count stands at no purchases and 35 sales.
On 6 October 2026 came the latest disclosure, an option exercise for €16k in Ligand Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrew Reardon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations61 total
340 shares@ US$52.27Common StockSEC:0001950232-26-000003:0
833 shares@ US$302.5107Common StockSEC:0001950232-26-000003:1
1,976 shares@ US$303.5444Common StockSEC:0001950232-26-000003:2
1,535 shares@ US$304.5154Common StockSEC:0001950232-26-000003:3
404 shares@ US$306.1834Common StockSEC:0001950232-26-000003:4
235 shares@ US$307.1911Common StockSEC:0001950232-26-000003:5
17 shares@ US$307.74Common StockSEC:0001950232-26-000003:6
2,115 shares@ US$286.35890.0099% mcap7.6% of flowCommon StockSEC:0002001011-26-000137:2
400 shares@ US$288.97920.0019% mcap1.4% of flowCommon StockSEC:0002001011-26-000137:4
300 shares@ US$283.98540.0014% mcap1.1% of flowCommon StockSEC:0002001011-26-000137:0
1,800 shares@ US$285.16710.0084% mcap6.4% of flowCommon StockSEC:0002001011-26-000137:1
385 shares@ US$287.52530.0018% mcap1.4% of flowCommon StockSEC:0002001011-26-000137:3
5,000 shares@ US$52.270.0043% mcap3.3% of flowCommon StockSEC:0002001011-26-000111:0
33 shares@ US$284.5530.0002% mcap0.1% of flowCommon StockSEC:0002001011-26-000111:2
1,214 shares@ US$287.77310.0057% mcap4.4% of flowCommon StockSEC:0002001011-26-000111:5
105 shares@ US$284.13750.0005% mcap0.4% of flowCommon StockSEC:0002001011-26-000111:1
157 shares@ US$285.73570.0007% mcap0.6% of flowCommon StockSEC:0002001011-26-000111:3
1,032 shares@ US$286.79680.0049% mcap3.7% of flowCommon StockSEC:0002001011-26-000111:4
356 shares@ US$288.74960.0017% mcap1.3% of flowCommon StockSEC:0002001011-26-000111:6
503 shares@ US$289.80220.0024% mcap1.8% of flowCommon StockSEC:0002001011-26-000111:7
200 shares@ US$290.600.0010% mcap0.7% of flowCommon StockSEC:0002001011-26-000111:8
991 shares@ US$291.71190.0047% mcap3.6% of flowCommon StockSEC:0002001011-26-000111:9
409 shares@ US$292.81910.0020% mcap1.5% of flowCommon StockSEC:0002001011-26-000111:10
5,000 shares@ US$52.270.0043% mcap3.3% of flowCommon StockSEC:0002001011-26-000108:1
104 shares@ US$310.20230.0005% mcap0.4% of flowCommon StockSEC:0002001011-26-000108:3
25 of 61 declarations
